Hemispherx Biopharma Board Names Thomas Equels as New President
August 13, 2015 at 08:35 AM EDT
Hemispherx Biopharma, Inc. (NYSE MKT: HEB) today announced that the Board has appointed Thomas Equels as the new President for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.